Stanford University


Inflammatory Syndrome and COVID-19: What Do Parents Need to Know?

On May 15th, Stanford Children's Health published information from infectious disease experts about a serious multi-system inflammatory condition that has appeared in children as a rare complication of COVID-19. The article is available on Stanford Children's Health's...

An Alternative to Remdesivir? Stanford Investigators Launch Peginterferon Lambda-1a Clinical Trial for COVID-19 Patients

Stanford Medical Center launched a clinical trial using a drug called interferon-lambda, a repurposed compound already tested against viruses that cause hepatitis. The investigators have set up a special tent and will administer one dose of the investigational product...

Pin It on Pinterest